BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Colchicine: Phase III data

Researchers at the hospital and colleagues reported data from the double-blind, Italian Phase III COPPS-POAF trial in 336 patients who had undergone cardiac surgery showing that twice-daily colchicine met the primary endpoint of significantly reducing the incidence of post-operative AF...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >